In
an effort to lower the cost of necessary drugs, Aurolab
created its Pharma Division in 1997 with the goal
of becoming a constant and consistent source of high
quality ophthalmic pharmaceuticals.
Aurolab has developed a wide range of ophthalmic drugs
that are cost effective, especially in developing
countries. The modern state-of-the-art pharmaceutical
formulation facility produces Eye Drops, Retinal products,
Viscoelastics, Ophthalmic Dyes and Antiseptics and
Disinfectants.
Aurolab
has received the prestigious CE mark
certification for HPMC and Trypan Blue, Perfluoro-n-octane, Silicon Oil and Brilliant
Blue G. The World Health Organization (WHO)
Good Manufacturing Practices (GMP)
certification was awarded to the division, confirming
that all AUROLAB pharmaceutical products are made
in compliance with international standards.
|
